insights_auto
Why is LGND down ၂.၄၄%?
Dive Deeperchevron_right
LGND:NASDAQ
Ligand Pharmaceuticals Inc
၃၀၃.၅၃ US$
arrow_downward
-၂.၄၄%(-၇.၆၀) 1D
၃၀၃.၅၃ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: အောက် ၁၃, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LGND...
Open
၃၁၁.၇၂ US$
High
၃၁၁.၇၂ US$
Low
၃၀၀.၂၃ US$
Mkt. cap
၆၀၅.၁၁ ဋေ
Avg. vol.
၂.၄၈ သိန်း
Volume
၁.၉၇ သိန်း
P/E ratio
၃၂.၂၈
52-wk high
၃၂၆.၆၃ US$
52-wk low
၁၇၅.၈၉ US$
EPS
၉.၄၀ US$
Beta
၁.၀၆
Shares outstanding
၁.၉၉ ကုဋေ
No. of employees
၄၇
Open
၃၁၁.၇၂ US$
High
၃၁၁.၇၂ US$
Low
၃၀၀.၂၃ US$
Mkt. cap
၆၀၅.၁၁ ဋေ
Avg. vol.
၂.၄၈ သိန်း
Volume
၁.၉၇ သိန်း
P/E ratio
၃၂.၂၈
52-wk high
၃၂၆.၆၃ US$
52-wk low
၁၇၅.၈၉ US$
EPS
၉.၄၀ US$
Beta
၁.၀၆
Shares outstanding
၁.၉၉ ကုဋေ
No. of employees
၄၇
News stories
From web sources and news partners
Benzinga
·
ပြီးခဲ့သည့် ၉ နာရီ
Here's How Much $1000 Invested In Ligand Pharmaceuticals 15 Years Ago Would Be Worth Today
Profile
Ligand Pharmaceuticals is an American biopharmaceutical company that focuses on acquiring and developing royalty-generating assets. As of 2024, the company's portfolio included royalty rights to approximately 90 pharmaceutical products across a range of therapeutic areas. Notable products from which Ligand receives royalties include the multiple myeloma treatments Kyprolis and Evomela, the kidney disease therapy Filspari, and the pneumococcal vaccine Vaxneuvance. The company also owns the drug development technology platform Captisol.
The company was founded in 1987 as Progenx by venture capitalist Brook Byers; it was renamed Ligand Pharmaceuticals in 1989 and went public in 1992. Following an accounting scandal that led to its delisting from the Nasdaq stock exchange in 2005, the company underwent a major restructuring. Under former CEO John Higgins, who took over in 2007, Ligand shifted its focus from drug development to its current business model of generating revenue from royalties and licensing payments.
Ligand has grown its portfolio primarily through acquisitions, including Pharmacopeia in 2008, CyDex Pharmaceuticals in 2011, and Pfenex in 2020. Wikipedia
About Ligand Pharmaceuticals Inc
CEO-
Employees၄၇
Foundedစက် ၁၉၈၇
HeadquartersJupiter, ဖလော်ရီဒါပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteligand.com